Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
about
Phase II study of the PI3K inhibitor BKM120 in patients with advanced or recurrent endometrial carcinoma: a stratified type I-type II study from the GINECO group.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Phase II study of the PI3K inh ...... I study from the GINECO group.
@en
Phase II study of the PI3K inh ...... I study from the GINECO group.
@nl
type
label
Phase II study of the PI3K inh ...... I study from the GINECO group.
@en
Phase II study of the PI3K inh ...... I study from the GINECO group.
@nl
prefLabel
Phase II study of the PI3K inh ...... I study from the GINECO group.
@en
Phase II study of the PI3K inh ...... I study from the GINECO group.
@nl
P2093
P2860
P356
P1476
Phase II study of the PI3K inh ...... I study from the GINECO group.
@en
P2093
A Lortholary
C Roemer-Becuwe
D Berton-Rigaud
E Kalbacher
P2860
P2888
P304
P356
10.1038/BJC.2016.430
P407
P577
2017-01-10T00:00:00Z
P6179
1049733476